Skip To Main Content
Redina Bardhi on Muck Rack

Redina Bardhi

As seen in: Wiley Online Library, PLOS, Genome Medicine, Practical Dermatology, JAAD Case Reports, JAAD International
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Redina

Contact Redina, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Subjective and objective assessment of color match of universal tinted sunscreens in Fitzpatrick skin phototypes I-VI

|
By Redina Bardhi, Mavra Masood, Mohsen Mokhtari, Deena Abdel-Gadir
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT Indermeet Kohli: La Roche Posay, Dermatologique, Pfizer, Beiersdorf (previously known as Bayer), American Skin Association, Dermatology Foundation, ISDIN, Member Board of Directors of Photodermatology Society, Associate Editor of Frontiers in Photobiology. Tasneem F. Mohammad: Beiersdorf, Ferndale Laboratories. Henry W.
Open in Who Shared Issue with article?

Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis

|
By Neil Jairath, Redina Bardhi, John S. Runge
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Background Large cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development. Objectives Here, we seek to characterize the clinicopathologic risk factors that predispose patients with SS to develop LCT. Methods We retrospectively evaluated all SS patient records available in the Michigan Medicine Cancer Registry from 2010–2021.
Open in Who Shared Issue with article?

Seborrheic Dermatitis Survey Shows Burdensome and Lengthy Path to Diagnosis

|
By Arif Musa, Redina Bardhi, Elizabeth Warbasse, Steven D. Daveluy
| Practical Dermatology Verified
Arcutis Biotherapeutics, Inc., shared results of a nationwide survey of adults with seborrheic dermatitis and the health care providers who treat them that highlights the long path to diagnosis and the general lack of awareness and education about the disease.
Open in Who Shared View Duplicates (23) Issue with article?
See all 7 articles